Rebecca Robbins

3 weeks ago | nytimes.com | Rebecca Robbins |Gina Kolata

Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat obesity and diabetes. Encouraging clinical trial results announced on Thursday stand to open up a huge market for a convenient daily pill to treat obesity and diabetes. The experimental drug, developed by Eli Lilly and known as orforglipron, is a type of medication known as a GLP-1.

3 weeks ago | virginislandsdailynews.com | Rebecca Robbins

Hundreds of thousands of Americans stand to soon lose their access to cheaper weight-loss drugs, with a federal crackdown on copycat versions threatening to disrupt treatment and raise costs. The Food and Drug Administration has ordered producers and sellers of the less expensive products to wind down operations in the coming weeks now that it has declared there are no longer shortages of the blockbuster drugs Wegovy and Zepbound.

4 weeks ago | nytimes.com | Rebecca Robbins |Dani Blum

U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or suspend treatment for patients. Copycat medications, produced through a process of mixing drug ingredients known as compounding, have spawned a multi-billion-dollar industry. Credit... Hilary Swift for The New York Times U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or suspend treatment for patients.

4 weeks ago | pressdemocrat.com | Rebecca Robbins

President Donald Trump’s decision to move a step closer to imposing tariffs on imported medicines poses considerable political risk, because Americans could face higher prices and more shortages of critical drugs. The Trump administration filed a federal notice Monday saying that it had begun an investigation into whether imports of medicines and pharmaceutical ingredients threaten America’s national security, an effort to lay the groundwork for possible tariffs on foreign-made drugs.

1 month ago | nytimes.com | Margot Sanger-Katz |Rebecca Robbins

Administration officials reversed a decision made during the Biden presidency that would have given millions of people access to weight-loss drugs paid for Medicare and Medicaid.